Lymphoepithelioma-like thymic carcinoma
diseaseOn this page
Also known as lymphoepithelial cancer of the Thymuslymphoepithelial cancer of Thymuslymphoepithelial Thymus cancerlymphoepithelioma-like carcinoma of the Thymuslymphoepithelioma-like carcinoma of Thymuslymphoepithelioma-like Thymus carcinomamalignant lymphoepithelial thymomathymic lymphoepithelioma-like carcinoma
Summary
Lymphoepithelioma-like thymic carcinoma (MONDO:0004297) is a cancer and 1 clinical trial. A subtype of nasopharyngeal type undifferentiated carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | lymphoepithelioma-like thymic carcinoma |
| Mondo ID | MONDO:0004297 |
| DOID | DOID:7599 |
| NCIT | C7998 |
| UMLS | C0279706 |
| MedGen | 79026 |
| GARD | 0023919 |
| Is cancer (heuristic) | yes |
Also known as: lymphoepithelial cancer of the Thymus · lymphoepithelial cancer of Thymus · lymphoepithelial Thymus cancer · lymphoepithelioma-like carcinoma of the Thymus · lymphoepithelioma-like carcinoma of Thymus · lymphoepithelioma-like thymic carcinoma · lymphoepithelioma-like Thymus carcinoma · malignant lymphoepithelial thymoma · thymic lymphoepithelioma-like carcinoma
Disease family
This is a subtype of nasopharyngeal type undifferentiated carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › large cell carcinoma › nasopharyngeal type undifferentiated carcinoma › lymphoepithelioma-like thymic carcinoma
Related subtypes (2): cervical lymphoepithelioma-like carcinoma, infiltrating bladder lymphoepithelioma-like carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04614818 | Not specified | UNKNOWN | A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like Carcinoma |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.